危重症患者静脉-静脉持续肾脏替代治疗期间中性粒细胞明胶酶相关脂质运载蛋白的清除情况 - Suppr

Suppr

超能文献

Neutrophil gelatinase-associated lipocalin clearance during veno-venous continuous renal replacement therapy in critically ill patients.

作者信息

de Geus Hilde R H, Betjes Michiel G H, Bakker Jan

出版信息

Intensive Care Med. 2010 Dec;36(12):2156-7. doi: 10.1007/s00134-010-2015-1. Epub 2010 Aug 19.

DOI:10.1007/s00134-010-2015-1

PMID:20721534

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2981741/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db1f/2981741/d9a9ac34f763/134_2010_2015_Fig1_HTML.jpg

相似文献

Neutrophil gelatinase-associated lipocalin clearance during veno-venous continuous renal replacement therapy in critically ill patients.

Intensive Care Med. 2010 Dec;36(12):2156-7. doi: 10.1007/s00134-010-2015-1. Epub 2010 Aug 19.

Neutrophil gelatinase-associated lipocalin levels during extracorporeal membrane oxygenation in critically ill children with congenital heart disease: preliminary experience.

Pediatr Crit Care Med. 2012 Jan;13(1):e51-4. doi: 10.1097/PCC.0b013e3181fe4717.

Biomarkers for acute kidney injury: is the serum creatinine worthless?

Pediatr Crit Care Med. 2012 Jan;13(1):119-20. doi: 10.1097/PCC.0b013e318202f5ed.

The plasma level and biomarker value of neutrophil gelatinase-associated lipocalin in critically ill patients with acute kidney injury are not affected by continuous venovenous hemofiltration and anticoagulation applied.

Crit Care. 2014 Apr 22;18(2):R78. doi: 10.1186/cc13838.

Is neutrophil gelatinase-associated lipocalin unaffected by convective continuous renal replacement therapy? Definitely … maybe.

Crit Care. 2015 Nov 17;19:392. doi: 10.1186/s13054-015-1104-5.

Potential role of neutrophil gelatinase-associated lipocalin in identifying critically ill patients with acute kidney injury stage 2-3 who subsequently require renal replacement therapy.

Ther Apher Dial. 2013 Jun;17(3):332-8. doi: 10.1111/1744-9987.12004. Epub 2013 Jan 22.

Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury--where do we stand today?

Nephrol Dial Transplant. 2011 Mar;26(3):762-4. doi: 10.1093/ndt/gfr006. Epub 2011 Feb 9.

[The effect of continuous veno venous hemofiltration on neutrophil gelatinase-associated lipocalin plasma levels in critically ill patients with acute kidney injury].

Zhonghua Nei Ke Za Zhi. 2018 Apr 1;57(4):285-289. doi: 10.3760/cma.j.issn.0578-1426.2018.04.011.

Intensive care.

Nephrol Dial Transplant. 2010 Mar;25(3):678-83. doi: 10.1093/ndt/gfq005.

The rise and fall of NGAL in acute kidney injury.

Blood Purif. 2014;37(4):304-10. doi: 10.1159/000364937. Epub 2014 Aug 21.

引用本文的文献

Current role of biomarkers in the initiation and weaning of kidney replacement therapy in acute kidney injury.

World J Nephrol. 2025 Mar 25;14(1):99802. doi: 10.5527/wjn.v14.i1.99802.

Urinary neutrophil gelatinase-associated lipocalin and plasma IL-6 in discontinuation of continuous venovenous hemodiafiltration for severe acute kidney injury: a multicenter prospective observational study.

Ann Intensive Care. 2023 May 15;13(1):42. doi: 10.1186/s13613-023-01137-6.

Effect of continuous renal replacement therapy on kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin in patients with septic acute kidney injury.

Exp Ther Med. 2017 Jun;13(6):3594-3602. doi: 10.3892/etm.2017.4436. Epub 2017 May 5.

The effect of continuous venovenous hemofiltration on neutrophil gelatinase-associated lipocalin plasma levels in patients with septic acute kidney injury.

BMC Nephrol. 2016 Oct 19;17(1):154. doi: 10.1186/s12882-016-0363-y.

Renal replacement therapy in acute kidney injury: controversy and consensus.

Crit Care. 2015 Apr 6;19(1):146. doi: 10.1186/s13054-015-0850-8.

Measuring biomarkers of acute kidney injury during renal replacement therapy: wisdom or folly?

Crit Care. 2014 Jun 19;18(3):155. doi: 10.1186/cc13933.

Crit Care. 2014 Apr 22;18(2):R78. doi: 10.1186/cc13838.

Peritoneal dialysis does not adversely affect kidney function recovery after congenital heart surgery.

Int J Artif Organs. 2014 Jan;37(1):39-47. doi: 10.5301/ijao.5000294. Epub 2014 Jan 20.

The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer.

Biochim Biophys Acta. 2012 Aug;1826(1):129-69. doi: 10.1016/j.bbcan.2012.03.008. Epub 2012 Mar 31.

Plasma neutrophil gelatinase-associated lipocalin clearance during venovenous hemodiafiltration.

Clin Exp Nephrol. 2012 Apr;16(2):356-7. doi: 10.1007/s10157-012-0604-8. Epub 2012 Feb 14.

本文引用的文献

Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population.

Intensive Care Med. 2010 Mar;36(3):444-51. doi: 10.1007/s00134-009-1711-1. Epub 2009 Dec 3.

Biomarkers and acute kidney injury: dining with the Fisher King?

Intensive Care Med. 2010 Mar;36(3):381-4. doi: 10.1007/s00134-009-1733-8. Epub 2009 Dec 3.

Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study.

Crit Care Med. 2009 Sep;37(9):2576-82. doi: 10.1097/CCM.0b013e3181a38241.

Dual action of neutrophil gelatinase-associated lipocalin.

J Am Soc Nephrol. 2007 Feb;18(2):407-13. doi: 10.1681/ASN.2006080882. Epub 2007 Jan 17.

Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery.

Lancet. 2005;365(9466):1231-8. doi: 10.1016/S0140-6736(05)74811-X.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验